Why the study?
Does aspirin or dipyridamole prevent thrombosis in dogs with experimentally injured peripheral arteries?
Does aspirin or dipyridamole prevent thrombosis in dogs with experimentally injured peripheral arteries?
Aspirin demonstrates significant anti-thrombotic properties in a canine model of arterial injury, whereas dipyridamole does not.
Aspirin may reduce thrombosis after arterial injury in dogs; leaves open translation to human peripheral interventions.
Summary The possible anti-thrombotic properties of drugs which interfere with platelet aggregation were studied. Segments of the peripheral arteries of dogs were isolated, injured either by endarterectomy or chemically by instillation of 0.1 N H2 S04 (chemical injury). Two days later, the segments were examined for the presence of thrombosis. In animals which received only a placebo, 29% of the chemically-injured segments and 43% of the endarterectomized segments became totally occluded with thrombi. Treatment with aspirin (600 mg per day) reduced this incidence to 2 and 11% respectively (p < .05) while treatment with dipyridamole (DPM) (200 mg per day) had no effect. In a second study, aspirin ingestion reduced the incidence of total occlusion in chemically-injured segments from 38 to 0%. Connective-tissue induced platelet aggregation decreased in aspirin treated animals, while DPM had no effect. The findings support previous suggestions that aspirin, perhaps by inhibiting platelet aggregation, has anti-thrombotic properties.
No takes yet. Share an insight, caveat, or question.
Danese et al. (1971) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: